...
首页> 外文期刊>Molecular pharmaceutics >In Vivo Antibacterial Efficacy of Nitric Oxide-Releasing Hyperbranched Polymers against Porphyromonas gingivalis
【24h】

In Vivo Antibacterial Efficacy of Nitric Oxide-Releasing Hyperbranched Polymers against Porphyromonas gingivalis

机译:在对卟啉单胞菌氏菌的一氧化氮释放超支化聚合物的体内抗菌效果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The in vivo antibacterial activity of NO-releasing hyperbranched polymers was evaluated against Porphyromonas gingivalis, a key oral pathogen associated with periodontitis, using a murine subcutaneous chamber model. Escalating doses of NO-releasing polymers (1.5, 7.5, and 37.5 mg/kg) were administered into a P. gingivalis-infected chamber once a day for 3 days. Chamber fluids were collected on day 4, with microbiological evaluation indicating a dose-dependent bactericidal action. In particular, NO-releasing polymers at 37.5 mg/kg (1170 mu g of NO/kg) achieved complete bacterial eradication (>6-log reduction in bacterial viability), demonstrating greater efficacy than amoxicillin (similar to 4-log reduction in bacterial viability), a commonly used antibiotic. Time-kill assays further revealed that largest dose (37.5 mg/kg; 1170 mu g of NO/kg) resulted in similar to 3-log killing of P. gingivalis after only a single dose. Based on these results, the potential clinical utility of NO-releasing hyperbranched polymers appears promising, particularly for oral health applications.
机译:使用鼠皮下腔室模型,评估无释放超支化聚合物的无释放超支化聚合物的体内抗菌活性。每天一次将升级的无释放聚合物(1.5,7.5和37.5mg / kg)施加到P.Gingivalis感染的室内3天。在第4天收集室液,微生物评估表明剂量依赖性杀菌作用。特别地,在37.5mg / kg(1170μgnO / kg)的无释放聚合物实现了完全的细菌根除(> 6-降低细菌活力),展示了比阿莫西林更高的疗效(类似于细菌的4-次数减少活力),常用的抗生素。时间杀死测定进一步揭示了最大剂量(37.5mg / kg;1170μgnO / kg)导致仅在单个剂量之后类似于3- kog杀伤p.gingivalis。基于这些结果,无释放超支化聚合物的潜在临床效用似乎有前途,特别是口服健康应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号